CeriBell, Inc. (NASDAQ:CBLL) Short Interest Up 16.0% in February

CeriBell, Inc. (NASDAQ:CBLL) was the recipient of a significant growth in short interest in February. As of February 27th, there was short interest totaling 1,925,021 shares, a growth of 16.0% from the February 12th total of 1,659,458 shares. Based on an average trading volume of 292,834 shares, the short-interest ratio is currently 6.6 days. Currently, 6.4% of the company’s shares are sold short. Currently, 6.4% of the company’s shares are sold short. Based on an average trading volume of 292,834 shares, the short-interest ratio is currently 6.6 days.

Insider Activity

In other CeriBell news, CTO Raymond Woo sold 8,087 shares of CeriBell stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $18.25, for a total transaction of $147,587.75. Following the completion of the sale, the chief technology officer directly owned 166,912 shares of the company’s stock, valued at $3,046,144. The trade was a 4.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Rebecca B. Robertson sold 2,500 shares of the company’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $21.89, for a total value of $54,725.00. Following the completion of the sale, the director owned 19,576 shares of the company’s stock, valued at $428,518.64. This represents a 11.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 239,627 shares of company stock valued at $4,912,660. Insiders own 20.10% of the company’s stock.

Hedge Funds Weigh In On CeriBell

A number of large investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of CeriBell by 3,971.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock valued at $28,000 after buying an additional 1,231 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in CeriBell during the third quarter valued at approximately $33,000. CWM LLC lifted its position in CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after acquiring an additional 1,697 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in CeriBell by 353.8% during the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after acquiring an additional 1,801 shares during the last quarter. Finally, Ameritas Investment Partners Inc. boosted its stake in CeriBell by 97.5% in the second quarter. Ameritas Investment Partners Inc. now owns 2,544 shares of the company’s stock valued at $48,000 after acquiring an additional 1,256 shares in the last quarter.

Wall Street Analysts Forecast Growth

CBLL has been the topic of several research reports. BTIG Research restated a “buy” rating and set a $30.00 price target on shares of CeriBell in a research note on Wednesday, January 28th. TD Cowen reiterated a “buy” rating on shares of CeriBell in a report on Tuesday, December 9th. Finally, Canaccord Genuity Group raised their target price on shares of CeriBell from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.67.

CeriBell Stock Down 3.1%

Shares of NASDAQ CBLL opened at $18.89 on Thursday. The company has a current ratio of 9.73, a quick ratio of 9.35 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $711.02 million, a PE ratio of -12.85 and a beta of 1.12. The stock’s fifty day simple moving average is $20.29 and its two-hundred day simple moving average is $16.89. CeriBell has a 12-month low of $10.01 and a 12-month high of $24.33.

CeriBell (NASDAQ:CBLL) last released its quarterly earnings results on Tuesday, February 24th. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.07. The firm had revenue of $24.78 million during the quarter, compared to analyst estimates of $23.95 million. CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97%. As a group, analysts expect that CeriBell will post -2.46 EPS for the current fiscal year.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.